See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
The Goldman Sachs Group, Inc. (GS) - free report >>
Citigroup Inc. (C) - free report >>
Target Corporation (TGT) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Goldman Sachs Group, Inc. (GS) - free report >>
Citigroup Inc. (C) - free report >>
Target Corporation (TGT) - free report >>
Image: Bigstock
Stock Market Roundup Jan. 18: TGT Down, Financial Stocks (GS, C) in Focus
On Wednesday, Target Corp. (TGT - Free Report) is the just the latest brick-and-mortar retailer to report dismal holiday season sales, and its stock took a huge hit as a result. In the financial sector, Goldman Sachs (GS - Free Report) and Citigroup (C - Free Report) were both on the move after reporting fourth-quarter earnings before the bell today. Goldman Sachs beat Street estimates on both the top and bottom lines, whole Citi posted mixed results.
Zacks #1 (Strong Buy) Biggest Movers
Value: AK Steel
Growth: United States Steel Corp. (X - Free Report)
Momentum: X
VGM: AKS
Major Indexes
DOW: 19,804.43 / -22.34 / -0.11%
S&P 500: 2,271.92 / +4.03 / +0.18%
NASDAQ: 5,555.56 / +16.83 / +0.30%
Top Headlines
Target Slides 6% on Disappointing Holiday Sales
Target is the latest retailer to report disappointing holiday sales, and its stock fell around 6% as a result. The retailer said that comparable sales fell 1.3% in November and December; any gains seen in its online business were outshone by increased difficulty in getting customers into its stores, as well as stiff price competition from rivals.
Here’s Why CoLucid Pharma is Skyrocketing 32% Today
Shares of biopharmaceutical company CoLucid Pharmaceuticals skyrocketed around 32% after Eli Lilly and Co. announced it is buying the company for a whopping $960 million. With the deal, Eli Lilly is gaining access to CoLucid’s experimental treatment for migraine, a large but under-treated condition that affects roughly 36 million Americans.
Bull of the Day: B&G Foods (BGS - Free Report)
B&G Foods (BGS - Free Report) is a food products company with a huge portfolio of well-known brands. B&G continues to grow organically and through acquisitions, and after better than expected results and revised guidance, analysts have raised estimates for the company. For this reason, B&G is Zacks’ Bull of the Day.
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>